Skip to main content
. 2016 Oct 12;7(49):80735–80750. doi: 10.18632/oncotarget.12598

Table 1. MSP positivity in the external validation cohort of FFPE tissue samples.

Gene Normal Cancer ADC SCC
TBX5 56% (9/16) 67% (8/12) 60% (3/5) 71% (5/7)
SOX14* 25% (4/16) 85% (11/13) 83% (5/6) 86% (6/7)
SOX1* 0% (0/15) 92% (11/12) 100% (5/5) 86% (6/7)
TBX20* 6% (1/17) 83% (10/12) 100% (5/5) 71% (5/7)
SLC6A5* 7% (1/15) 83% (10/12) 100% (5/5) 71% (5/7)
GFRA1* 0% (0/11) 83% (10/12) 83% (5/6) 83% (5/6)
*

the positive rates in normal and cancer samples differ (P < 0.05).